SG11201602889TA - Novel polypeptides - Google Patents
Novel polypeptidesInfo
- Publication number
- SG11201602889TA SG11201602889TA SG11201602889TA SG11201602889TA SG11201602889TA SG 11201602889T A SG11201602889T A SG 11201602889TA SG 11201602889T A SG11201602889T A SG 11201602889TA SG 11201602889T A SG11201602889T A SG 11201602889TA SG 11201602889T A SG11201602889T A SG 11201602889TA
- Authority
- SG
- Singapore
- Prior art keywords
- novel polypeptides
- polypeptides
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201318941A GB201318941D0 (en) | 2013-10-28 | 2013-10-28 | Novel polypeptides |
| GB201410265A GB201410265D0 (en) | 2014-06-10 | 2014-06-10 | Novel polypeptides |
| PCT/GB2014/053199 WO2015063465A2 (en) | 2013-10-28 | 2014-10-28 | Novel polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201602889TA true SG11201602889TA (en) | 2016-05-30 |
Family
ID=51871092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201602889TA SG11201602889TA (en) | 2013-10-28 | 2014-10-28 | Novel polypeptides |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10294274B2 (en) |
| EP (1) | EP3062823B1 (en) |
| JP (3) | JP2017502921A (en) |
| CN (1) | CN105683211B (en) |
| AU (2) | AU2014343503B2 (en) |
| BR (1) | BR112016008996B1 (en) |
| CA (1) | CA2927554C (en) |
| ES (1) | ES2715379T3 (en) |
| NZ (1) | NZ719510A (en) |
| RU (1) | RU2674604C2 (en) |
| SG (1) | SG11201602889TA (en) |
| WO (1) | WO2015063465A2 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10800813B2 (en) | 2011-10-07 | 2020-10-13 | Bicyclerd Limited | Modulation of structured polypeptide specificity |
| GB201306623D0 (en) | 2013-04-11 | 2013-05-29 | Bicycle Therapeutics Ltd | Modulation of structured polypeptide specificity |
| NZ719510A (en) * | 2013-10-28 | 2022-07-01 | Bicyclerd Ltd | Novel polypeptides |
| GB201607827D0 (en) | 2016-05-04 | 2016-06-15 | Bicycle Therapeutics Ltd | Bicyclic peptide-toxin conjugates specific for MT1-MMP |
| CN110603261A (en) | 2016-12-23 | 2019-12-20 | 拜斯科阿迪有限公司 | Peptide derivatives having novel bond structure |
| US10899798B2 (en) | 2017-06-26 | 2021-01-26 | Bicyclerd Limited | Bicyclic peptide ligands with detectable moieties and uses thereof |
| CN107557476A (en) * | 2017-08-25 | 2018-01-09 | 华侨大学 | It is a kind of to analyze method of the thuricade-1 to target worm hypoactivity reason |
| JP2020532586A (en) * | 2017-08-31 | 2020-11-12 | シンガポール ヘルス サービシーズ プライベート リミテッド | ANGIO-3 for the treatment of retinal vascular disease |
| TWI825046B (en) | 2017-12-19 | 2023-12-11 | 英商拜西可泰克斯有限公司 | Bicyclic peptide ligands specific for epha2 |
| GB201721265D0 (en) | 2017-12-19 | 2018-01-31 | Bicyclerd Ltd | Bicyclic peptide ligands specific for EphA2 |
| US11180531B2 (en) | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
| GB201810327D0 (en) * | 2018-06-22 | 2018-08-08 | Bicycletx Ltd | Peptide ligands for binding to IL-17 |
| GB201810316D0 (en) | 2018-06-22 | 2018-08-08 | Bicyclerd Ltd | Peptide ligands for binding to EphA2 |
| US20220227813A1 (en) * | 2019-05-14 | 2022-07-21 | Ichimaru Pharcos Co., Ltd. | Ras INHIBITORY PEPTIDE |
| WO2021198534A1 (en) | 2020-04-04 | 2021-10-07 | Oxurion NV | Plasma kallikrein inhibitors for use in the treatment of coronaviral disease |
| EP4149954A1 (en) * | 2020-05-15 | 2023-03-22 | BicycleTX Limited | Anti-infective bicyclic peptide ligands |
| WO2023144030A1 (en) | 2022-01-31 | 2023-08-03 | Oxurion NV | Plasma kallikrein inhibitor therapy for anti-vegf sensitization |
| WO2023148016A1 (en) | 2022-02-04 | 2023-08-10 | Oxurion NV | Biomarker for plasma kallikrein inhibitor therapy response |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0205527D0 (en) * | 2002-03-08 | 2002-04-24 | Ferring Bv | Inhibitors |
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| PT1844337E (en) | 2005-01-24 | 2014-04-03 | Pepscan Systems Bv | Binding compounds, immunogenic compounds and peptidomimetics |
| JP5337493B2 (en) | 2006-03-16 | 2013-11-06 | ダイアックス コーポレーション | Compositions and methods for treating ophthalmic disorders using peptides that inhibit serine proteases |
| EP2653543A1 (en) * | 2008-02-05 | 2013-10-23 | Bicycle Therapeutics Limited | Methods and Compositions |
| GB0913775D0 (en) * | 2009-08-06 | 2009-09-16 | Medical Res Council | Multispecific peptides |
| JP2013518807A (en) * | 2010-02-04 | 2013-05-23 | メディカル リサーチ カウンシル | Multispecific peptide |
| US10800813B2 (en) * | 2011-10-07 | 2020-10-13 | Bicyclerd Limited | Modulation of structured polypeptide specificity |
| GB201117428D0 (en) * | 2011-10-07 | 2011-11-23 | Bicycle Therapeutics Ltd | Structured polypeptides with sarcosine linkers |
| US20140274759A1 (en) * | 2013-03-15 | 2014-09-18 | Bicycle Therapeutics Limited | Modification of polypeptides |
| GB201306623D0 (en) * | 2013-04-11 | 2013-05-29 | Bicycle Therapeutics Ltd | Modulation of structured polypeptide specificity |
| NZ719510A (en) * | 2013-10-28 | 2022-07-01 | Bicyclerd Ltd | Novel polypeptides |
-
2014
- 2014-10-28 NZ NZ719510A patent/NZ719510A/en unknown
- 2014-10-28 AU AU2014343503A patent/AU2014343503B2/en active Active
- 2014-10-28 ES ES14796237T patent/ES2715379T3/en active Active
- 2014-10-28 CN CN201480059396.5A patent/CN105683211B/en active Active
- 2014-10-28 CA CA2927554A patent/CA2927554C/en active Active
- 2014-10-28 WO PCT/GB2014/053199 patent/WO2015063465A2/en active Application Filing
- 2014-10-28 US US15/029,248 patent/US10294274B2/en active Active
- 2014-10-28 EP EP14796237.7A patent/EP3062823B1/en active Active
- 2014-10-28 BR BR112016008996-0A patent/BR112016008996B1/en active IP Right Grant
- 2014-10-28 JP JP2016526871A patent/JP2017502921A/en active Pending
- 2014-10-28 SG SG11201602889TA patent/SG11201602889TA/en unknown
- 2014-10-28 RU RU2016120641A patent/RU2674604C2/en active
-
2019
- 2019-01-03 US US16/239,264 patent/US10894808B2/en active Active
- 2019-02-14 JP JP2019024205A patent/JP2019112412A/en active Pending
- 2019-02-20 AU AU2019201173A patent/AU2019201173B2/en active Active
-
2021
- 2021-03-19 JP JP2021046348A patent/JP7170081B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2927554A1 (en) | 2015-05-07 |
| EP3062823B1 (en) | 2018-12-12 |
| BR112016008996A2 (en) | 2017-10-03 |
| ES2715379T3 (en) | 2019-06-04 |
| JP7170081B2 (en) | 2022-11-11 |
| US10894808B2 (en) | 2021-01-19 |
| AU2019201173A1 (en) | 2019-03-07 |
| CN105683211A (en) | 2016-06-15 |
| EP3062823A2 (en) | 2016-09-07 |
| WO2015063465A2 (en) | 2015-05-07 |
| RU2674604C2 (en) | 2018-12-11 |
| RU2016120641A (en) | 2017-12-05 |
| RU2016120641A3 (en) | 2018-07-02 |
| CA2927554C (en) | 2022-11-29 |
| WO2015063465A3 (en) | 2015-09-11 |
| AU2019201173B2 (en) | 2019-11-21 |
| JP2017502921A (en) | 2017-01-26 |
| AU2014343503A1 (en) | 2016-05-12 |
| US20190233475A1 (en) | 2019-08-01 |
| NZ719510A (en) | 2022-07-01 |
| BR112016008996B1 (en) | 2023-01-24 |
| AU2014343503B2 (en) | 2019-01-17 |
| US20160222063A1 (en) | 2016-08-04 |
| US10294274B2 (en) | 2019-05-21 |
| JP2019112412A (en) | 2019-07-11 |
| CN105683211B (en) | 2020-10-20 |
| JP2021098755A (en) | 2021-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202004893B (en) | Materials | |
| HK1216756A1 (en) | New polypeptides | |
| GB201311475D0 (en) | Polypeptides | |
| SG11201602889TA (en) | Novel polypeptides | |
| SG11201506876XA (en) | Modification of polypeptides | |
| EP2968338A4 (en) | Novel uses | |
| EP2956141A4 (en) | Novel uses | |
| HRP20180452T1 (en) | Peptides | |
| PL3061771T3 (en) | Novel four-ctl epitope-joined peptide | |
| HK1211596A1 (en) | Peptide | |
| GB201309421D0 (en) | Polypeptides | |
| HK1211595A1 (en) | Peptide | |
| HK1198769A1 (en) | Novel peptide | |
| GB201315130D0 (en) | Peptides | |
| ZA201506407B (en) | New polypeptides | |
| PL3080276T3 (en) | Entomotoxic polypeptides | |
| GB201318941D0 (en) | Novel polypeptides | |
| GB201305465D0 (en) | Novel peptides | |
| GB201316660D0 (en) | Peptides | |
| GB201300381D0 (en) | Peptides | |
| GB201303977D0 (en) | Binding polypeptides | |
| GB201319812D0 (en) | Lavark variations | |
| GB201303979D0 (en) | Detecting polypeptides |